Study investigates SARS-CoV-2 escape from nirmatrelvir By admin | June 10, 2022 0 Comment Researchers assessed SARS-CoV-2 Alpha, Delta, and Omicron variants’ resistance to nirmatrelvir, a protease inhibitor of SARS-CoV-2.